Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.
Centre for Tumour Biology, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.
Trends Cancer. 2023 Apr;9(4):326-338. doi: 10.1016/j.trecan.2023.01.002. Epub 2023 Feb 2.
Ductal carcinoma in situ (DCIS) is a pre-invasive form of breast cancer where neoplastic luminal cells are confined to the ductal tree. While as many as 70% of DCIS cases will remain indolent, most women are treated with surgery, often combined with endocrine and radiotherapies. Overtreatment is therefore a major issue, demanding new methods to stratify patients. Somewhat paradoxically, the neoplastic cells in DCIS are genetically comparable to those in invasive disease, suggesting the tumour microenvironment is the driving force for progression. Clinical and mechanistic studies highlight the complex DCIS microenvironment, with multiple cell types competing to regulate progression. Here, we examine recent studies detailing distinct aspects of the DCIS microenvironment and discuss how these may inform more effective care.
导管原位癌(DCIS)是一种乳腺癌的早期浸润形式,其中肿瘤性腔上皮细胞局限于导管树。尽管多达 70%的 DCIS 病例处于惰性状态,但大多数女性仍接受手术治疗,通常结合内分泌和放射治疗。因此,过度治疗是一个主要问题,需要新的方法来对患者进行分层。有些矛盾的是,DCIS 中的肿瘤细胞在遗传上与浸润性疾病中的细胞相似,这表明肿瘤微环境是疾病进展的驱动力。临床和机制研究强调了 DCIS 微环境的复杂性,其中多种细胞类型竞相调节进展。在这里,我们研究了最近详细描述 DCIS 微环境不同方面的研究,并讨论了这些研究如何为更有效的治疗提供信息。